Filed with the SEC on · Summarized by InvestorsBot
Robert B. Ford, Abbott Laboratories’ chairman and CEO and a director, sold 218,535 shares at $115.57 each for about $25.3 million, leaving him with 486,758 shares. He also sold 180,297 shares at $116.19 each for about $20.9 million, leaving him with 306,461 shares; total reported sales were approximately $46.2 million.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeAbbott Agrees to $670 Million Settlement in Preterm Formula Litigation
8-K · August 20, 2026
Abbott Agrees to Pay $670 Million to Resolve Preterm Formula Claims
8-K · August 20, 2026
Abbott (via Badger Merger Sub I) has an Agreement & Plan of Merger with Exact Sciences dated Nov 19, 2025…
8-K · March 23, 2026
Abbott ($ABT) closed its acquisition of Exact Sciences ($EXAS) on Mar 23, 2026.
8-K · March 23, 2026
Abbott filed an 8‑K (Item 9.01) on Mar 9, 2026 furnishing an indenture and note forms for debt: Floating…
8-K · March 9, 2026
Abbott Labs 8‑K filed 2026‑03‑09: Item 2.03 simply incorporates Item 1.01 by reference — it does not…
8-K · March 9, 2026